Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Platelet Rich Plasma for Chronic Low Back Pain
NCT02983747Unknown
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Nov 2019
- Primary completion
- Dec 2022
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Trial of autologous platelet-rich plasma in chronic low back pain (CLBP) (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoint: Visual Analog Scale at 1 year. Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT02983747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02983747.